PICARD MEDICAL INC (PMI) Fundamental Analysis & Valuation

NYSEARCA:PMI • US71953R1086

Current stock price

0.9437 USD
-0.05 (-4.68%)
At close:
0.9625 USD
+0.02 (+1.99%)
After Hours:

This PMI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PMI Profitability Analysis

1.1 Basic Checks

  • In the past year PMI has reported negative net income.
PMI Yearly Net Income VS EBIT VS OCF VS FCFPMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • PMI has a worse Return On Assets (-202.83%) than 90.43% of its industry peers.
Industry RankSector Rank
ROA -202.83%
ROE N/A
ROIC N/A
ROA(3y)-145.47%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PMI Yearly ROA, ROE, ROICPMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 200 400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PMI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PMI Yearly Profit, Operating, Gross MarginsPMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -100 -200 -300 -400 -500

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. PMI Health Analysis

2.1 Basic Checks

  • PMI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, PMI has about the same amount of shares outstanding.
  • PMI has a worse debt/assets ratio than last year.
PMI Yearly Shares OutstandingPMI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M
PMI Yearly Total Debt VS Total AssetsPMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -13.66, we must say that PMI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -13.66, PMI is doing worse than 86.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.66
ROIC/WACCN/A
WACC7.43%
PMI Yearly LT Debt VS Equity VS FCFPMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

  • PMI has a Current Ratio of 0.21. This is a bad value and indicates that PMI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PMI's Current ratio of 0.21 is on the low side compared to the rest of the industry. PMI is outperformed by 93.62% of its industry peers.
  • PMI has a Quick Ratio of 0.21. This is a bad value and indicates that PMI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PMI has a worse Quick ratio (0.06) than 96.28% of its industry peers.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.06
PMI Yearly Current Assets VS Current LiabilitesPMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. PMI Growth Analysis

3.1 Past

  • The earnings per share for PMI have decreased strongly by -31.86% in the last year.
  • PMI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.93%.
EPS 1Y (TTM)-31.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-12.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMI Yearly Revenue VS EstimatesPMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

Find the best growth stocksShow best growing peers

0

4. PMI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PMI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PMI Price Earnings VS Forward Price EarningsPMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PMI Per share dataPMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PMI Dividend Analysis

5.1 Amount

  • No dividends for PMI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PMI Fundamentals: All Metrics, Ratios and Statistics

PICARD MEDICAL INC

NYSEARCA:PMI (4/10/2026, 8:04:00 PM)

After market: 0.9625 +0.02 (+1.99%)

0.9437

-0.05 (-4.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-25
Earnings (Next)N/A
Inst Owners9.89%
Inst Owner Change0%
Ins Owners7.02%
Ins Owner Change0%
Market Cap70.95M
Revenue(TTM)4.39M
Net Income(TTM)-23.74M
AnalystsN/A
Price TargetN/A
Short Float %2.51%
Short Ratio0.72
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.84
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.06
BVpS-0.46
TBVpS-0.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -202.83%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-145.47%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.06
Altman-Z -13.66
F-ScoreN/A
WACC7.43%
ROIC/WACCN/A
Cap/Depr(3y)2.17%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.28%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-11.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.66%
OCF growth 3YN/A
OCF growth 5YN/A

PICARD MEDICAL INC / PMI Fundamental Analysis FAQ

What is the fundamental rating for PMI stock?

ChartMill assigns a fundamental rating of 0 / 10 to PMI.


What is the valuation status for PMI stock?

ChartMill assigns a valuation rating of 0 / 10 to PICARD MEDICAL INC (PMI). This can be considered as Overvalued.


Can you provide the profitability details for PICARD MEDICAL INC?

PICARD MEDICAL INC (PMI) has a profitability rating of 0 / 10.


What is the financial health of PICARD MEDICAL INC (PMI) stock?

The financial health rating of PICARD MEDICAL INC (PMI) is 0 / 10.